SCHEMBL32670495

SCHEMBL32670495

ClCc1ccc(Oc2cccc(Cl)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
AR P10275 1/20 0.44
MAOB P27338 2/20 0.44
SLC6A4 P31645 2/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
HTR2A P28223 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN5A Q14524 1/20 0.43
SCN9A Q15858 1/20 0.43
TTR P02766 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9502764 1.00 LPAR1 (0.45) LPAR1LPAR5ARMAOBSLC6A4
SCHEMBL8549352 0.88 ALDH1A1 (0.54) MAOBTTRALDH1A1MEN1MITF
SCHEMBL11315543 0.87 CYP3A4 (0.44) ARMAOBSLC6A4SLC6A2SLC6A3
SCHEMBL10715309 0.86 MAPT (0.54) ARMAOBSLC6A4SLC6A2SLC6A3
SCHEMBL507152 0.85 ST14 (0.62) LPAR1LPAR5ARMAOBSCN5A
SCHEMBL9428779 0.84 LPAR1 (0.44) LPAR1LPAR5ARMAOBSLC6A4
SCHEMBL12603799 0.84 ALDH1A1 (0.48) LPAR1LPAR5ARMAOBSLC6A4
SCHEMBL29349910 0.82 MAOA (0.52) ARMAOBSLC6A4HTR2AKCNH2
SCHEMBL3716891 0.82 MAOA (0.52) ARMAOBSLC6A4HTR2AKCNH2
SCHEMBL29924283 0.82 RHEB (0.52) ARMAOBSLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES SCN1B, SCN2B, SCN11A LPAR1 1484/4885LPAR5 1316/4885AR 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.